WAC/RET: A Novel RET Oncogenic Fusion Variant in Non-Small Cell Lung Carcinoma

被引：8
|
作者：
Velcheti, Vamsidhar [1 ]
Madison, Russell [2 ]
Ali, Siraj M. [2 ]
Schrock, Alexa B. [2 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Fdn Med, Cambridge, MA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 07期
关键词：
D O I：
10.1016/j.jtho.2018.03.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E122 / E123
页数：3
相关论文
共 50 条
  • [41] Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas
    Belluomini, Lorenzo
    Avancini, Alice
    Pasqualin, Luca
    Insolda, Jessica
    Sposito, Marco
    Menis, Jessica
    Tregnago, Daniela
    Trestini, Ilaria
    Ferrara, Miriam Grazia
    Bria, Emilio
    Milella, Michele
    Pilotto, Sara
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (08) : 785 - 794
  • [42] Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
    Fangdi Sun
    Caroline E. McCoach
    Current Treatment Options in Oncology, 2021, 22
  • [43] Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion plus Non-Small Cell Lung Cancer
    Zhou, Q.
    Wu, Y.
    Chang, J.
    Wang, H.
    Fan, Y.
    Zhao, J.
    Wu, G.
    Sun, Y.
    Sun, M.
    Wang, X.
    Shi, H.
    Nian, W.
    Wang, K.
    Zheng, X.
    Qu, L.
    Yao, S.
    Shen, Z.
    Li, P.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S889 - S890
  • [44] Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer
    Zhou, Qing
    Zhao, Jun
    Chang, Jianhua
    Wang, Huijie
    Fan, Yun
    Wang, Ke
    Wu, Gang
    Nian, Weiqi
    Sun, Yuping
    Sun, Meili
    Wang, Xiangcai
    Shi, Huaqiu
    Zheng, Xiangqian
    Yao, Sheng
    Qin, Mengmeng
    Shen, Zhenwei
    Yang, Jason
    Wu, Yi-Long
    CANCER, 2023, 129 (20) : 3239 - 3251
  • [45] The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients
    Guowu Wu
    Longhua Guo
    Yinfang Gu
    Tanxiao Huang
    Ming Liu
    Xiaofang Zou
    Bo Yang
    Ping Huang
    Chunling Wen
    Lilan Yi
    Wenting Liao
    Dongdong Zhao
    Junlin Zhu
    Xiaoni Zhang
    Yuanyuan Liu
    Yan Yin
    Shifu Chen
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 1019 - 1028
  • [46] High Incidence of CNS Metastases in Advanced or Recurrent Non-Small Cell Lung Cancer Patients with RET Fusion
    Lee, J.
    Ku, B. M.
    Shim, J. H.
    Choi, Y. L.
    Sun, J.
    Lee, S.
    Ahn, J. S.
    Park, K.
    Ahn, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S851 - S852
  • [47] The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients
    Wu, Guowu
    Guo, Longhua
    Gu, Yinfang
    Huang, Tanxiao
    Liu, Ming
    Zou, Xiaofang
    Yang, Bo
    Huang, Ping
    Wen, Chunling
    Yi, Lilan
    Liao, Wenting
    Zhao, Dongdong
    Zhu, Junlin
    Zhang, Xiaoni
    Liu, Yuanyuan
    Yin, Yan
    Chen, Shifu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) : 1019 - 1028
  • [48] Therapeutic Advances in the Management of Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
    Sun, Fangdi
    McCoach, Caroline E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (08)
  • [49] Effect of the RET Inhibitor Vandetanib in a Patient With RET Fusion-Positive Metastatic Non-Small-Cell Lung Cancer
    Falchook, Gerald S.
    Ordonez, Nelson G.
    Bastida, Christel C.
    Stephens, Philip J.
    Miller, Vincent A.
    Gaido, Lindsay
    Jackson, Tiffiny
    Karp, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15) : E141 - E144
  • [50] LIBRETTO-431: Selpercatinib in treatment (Tx)-naive patients with RET fusion-positive (RET plus ) non-small cell lung cancer (NSCLC)
    Loong, H. H. F.
    Goto, K.
    Elamin, Y. Y.
    Solomon, B.
    Santini, F. C.
    Soldatenkova, V.
    Sashegyi, A.
    Lin, A. Bence
    Lin, B. K.
    Wolf, J.
    Oxnard, G. R.
    Zhou, C.
    Drilon, A.
    Park, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S893 - S893
12345